Matthew Cooper

Investor profile

Matthew Cooper

Angel, Operator angel

Palo Alto·California·United States7known investments

Matthew Cooper is an angel investor and operator angel based in Palo Alto, California, United States. The known portfolio counts 7 companies: Carmenta Bioscience, Avails Medical, Inc., Preeclampsia Foundation, Pulsra, UCSF, NeoSeq and Stanford University School of Medicine.

Is Matthew Cooper a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Focus
BiotechDiagnosticsLiquid BiopsyMedTech

Contacts

mat***@***.comPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Matthew Cooper portfolio companies (7)

  • Carmenta Bioscience
  • Avails Medical, Inc.
  • Preeclampsia Foundation
  • Pulsra
  • UCSF
  • NeoSeq
  • Stanford University School of Medicine

Investor Profile

The known portfolio sits in sector Healthcare, and focus areas Biotech, Diagnostics, Liquid Biopsy and MedTech.

Reviewing the investment history helps decide whether there is a realistic fit before reaching out.

Similar investors

Showing 20 of 99

Chris Jackson

Chris Jackson

angel investor and operator angel

New York, United States

AngelOperator angel
Jeff Huber

Jeff Huber

angel investor and operator angel

Seattle, United States

AngelOperator angel
Michael Henry

Michael Henry

Member

Berkeley, United States

Angel
PC

Paco Cifuentes

angel investor

San Francisco, United States

Angel
JK

Jeffrey Kaditz

angel investor

Angel
JK

Jack Kraeutler

operator angel

Cincinnati, United States

Operator angel
Michael Jin

Michael Jin

Managing Partner

Palo Alto, United States

AngelOperator angel
MK

Max Kolysh

angel investor

San Francisco, United States

Angel
CM

Craig Muir

operator angel

Davis, United States

Operator angel
Andrew Offer

Andrew Offer

General Partner & Chief Executive Officer

Dallas, United States

AngelOperator angel
Matt Krisiloff

Matt Krisiloff

Partner and Co-Founder

San Francisco, United States

AngelOperator angel
Steven Collens

Steven Collens

CEO

Chicago, United States

AngelOperator angel
Scott H. Cohen

Scott H. Cohen

angel investor and operator angel

Santa Monica, United States

AngelOperator angel
Alon Altschuler

Alon Altschuler

angel investor and syndicate member

Boston, United States

AngelSyndicate / Angel group
David Mallery

David Mallery

angel investor and operator angel

San Diego, United States

AngelOperator angel
Robin Stracey

Robin Stracey

angel investor and operator angel

Reno, United States

AngelOperator angel
Mark Miller

Mark Miller

angel investor

Los Angeles, United States

Angel
Raymond McCauley

Raymond McCauley

Board Member

Mountain View, United States

AngelSyndicate / Angel group
JM

Jonathan Milner

angel investor and operator angel

Cambridge, United Kingdom

AngelOperator angel
Matthew Cohen

Matthew Cohen

angel investor and operator angel

New York, United States

AngelOperator angel
+79moreAvailable after registration

Frequently asked questions

Who is Matthew Cooper?

Matthew Cooper is an angel investor and operator angel based in Palo Alto, California, United States with 7 known investments on file, among them Carmenta Bioscience, Avails Medical, Inc. and Preeclampsia Foundation. The sections above list the sectors attached to that record.

What does Matthew Cooper invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Liquid Biopsy and MedTech. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.

How do I contact Matthew Cooper?

An email address, a phone number and a LinkedIn page are on file for Matthew Cooper. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal